TomoTherapy Has Filed For $201.25 Million IPO
February 12, 2007 - TomoTherapy Inc., a Madison, WI based developer of the Hi-Art cancer treatment on-board CT imaging radiation therapy, today filed for a $201.25 million IPO. Their plans are to trade on Nasdaq with ticker symbol TTPY and Merrill-Lynch will be the lead underwriter. Open Prairie Ventures invested in TomoTherapy in 2001 prior to FDA clearance of the Hi-Art System.
http://www.tomotherapy.com